Revolutionary treatments for a deadly type of brain cancer could be on the horizon, thanks to groundbreaking new research from King’s College Hospital NHS Trust, writes Dunya Simoes…
Diffuse gliomas are difficult to treat, aggressive brain tumours with a low chance of recovery.
However, researchers say the results of a ground-breaking study, published in Nature Communications, could help medics better predict the outcome of glioma cancer patients, and make way for more precise treatments and drugs.
Professor Keyoumars Ashkan, a consultant neurosurgeon at King’s College Hospital NHS Foundation Trust, co-authored the report which now presents the largest-ever study of genomic data in brain tumour patients.
“We are extremely proud to have created such an invaluable resource for clinicians to better predict outcomes and develop treatments for patients with glioma that are tailored to the tumour’s unique genetic makeup,” he said.
“These findings are the result of nine years of research, involving almost all brain tumour services in the UK, and have the potential to transform the way we treat patients with glioma across the world.”
Almost fifty authors were named in the research paper which analysed approximately 100,000 genomes and more than 400 patients.
